SCHEMBL7082872

SCHEMBL7082872

COC(c1ccccc1)C1CCN(c2ccc(C(=O)O)cc2)CC1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
USP2 O75604 1/20 0.56
FPR2 P25090 1/20 0.45
PROKR1 Q8TCW9 1/20 0.45
GAA P10253 1/20 0.44
KDM4E B2RXH2 1/20 0.43
CASR P41180 4/20 0.43
KMT2A Q03164 2/20 0.43
SRD5A1 P18405 1/20 0.42
NPC1 O15118 2/20 0.41
RAB9A P51151 2/20 0.41
ALDH1A1 P00352 1/20 0.41
LMNA P02545 1/20 0.41
TP53 P04637 1/20 0.41
MAPT P10636 1/20 0.41
HPGD P15428 1/20 0.41
ALOX15 P16050 1/20 0.41
TSHR P16473 1/20 0.41
STAT1 P42224 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
HSD17B10 Q99714 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7082982 0.93 USP2 (0.49) USP2FPR2PROKR1GAAKDM4E
SCHEMBL6374861 0.88 NOX1 (0.45) USP2FPR2PROKR1GAATSHR
SCHEMBL6379753 0.88 NPY2R (0.52) FPR2PROKR1GAAKDM4EKMT2A
SCHEMBL6375313 0.87 KMT2A (0.45) USP2FPR2PROKR1KMT2ANPC1
SCHEMBL6372155 0.85 ALDH1A1 (0.45) GAAKMT2ANPC1RAB9AALDH1A1
SCHEMBL7135104 0.82 USP2 (0.63) USP2KDM4ECASRKMT2ARAB9A
SCHEMBL7087494 0.80 USP2 (0.53) USP2GAAKDM4ECASRKMT2A
SCHEMBL6379080 0.80 NOX1 (0.46) USP2FPR2PROKR1KMT2ANPC1
SCHEMBL24184005 0.79 USP2 (0.44) USP2CASRALDH1A1LMNATP53
SCHEMBL28973706 0.79 USP2 (0.44) USP2CASRALDH1A1LMNATP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2003068807-A2 ECHINOCANDIN CYCLIC PEPTIDE DERIVATIVES FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2003-08-21 WO disclosed